Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Increased Risk for Cardiovascular Disease”

44 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 44 results

Large-scale testing (Phase 3)Ended earlyNCT01213394
What this trial is testing

Mycophenolate Mofetil for Reducing Cardiovascular Risk in Renal Transplant Recipients

Who this might be right for
Kidney TransplantationCardiovascular Diseases
Ramesh Prasad 2
Testing effectiveness (Phase 2)Study completedNCT04216589
What this trial is testing

Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)

Who this might be right for
HIV InfectionsNon-Alcoholic Fatty Liver Disease
National Institute of Allergy and Infectious Diseases (NIAID) 51
Not applicableLooking for participantsNCT00552357
What this trial is testing

Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation

Who this might be right for
Primary Graft DysfunctionLung Transplantation
University of Pennsylvania 1,150
Not applicableStudy completedNCT01901874
What this trial is testing

The Gore SCAFFOLD Clinical Study

Who this might be right for
Carotid Artery DiseaseCarotid Artery Stenosis
W.L.Gore & Associates 312
Not applicableStudy completedNCT02958943
What this trial is testing

Electronic Alerts for Stroke Prevention in Atrial Fibrillation

Who this might be right for
Atrial FibrillationStroke
Brigham and Women's Hospital 798
Post-approval studies (Phase 4)Ended earlyNCT01591902
What this trial is testing

Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®

Who this might be right for
Diabetic RetinopathyHIV
Theratechnologies 129
Not applicableStudy completedNCT03911141
What this trial is testing

Behavioral Economic Approaches to Increase Physical Activity Among Patients With Elevated Risk for Cardiovascular Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
University of Pennsylvania 1,062
Not applicableStudy completedNCT02035254
What this trial is testing

A Multidisciplinary e-Health Program to Promote Regular Physical Activity

Who this might be right for
Increased Risk for Cardiovascular Disease
McGill University 93
Not applicableStudy completedNCT00810992
What this trial is testing

Traditional Tibetan Medicine for Patients With Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
University Hospital Tuebingen 524
Not applicableStudy completedNCT00790491
What this trial is testing

Automated Guidance Tool for Medical Encounters Addressing Therapeutic Lifestyle Changes (AuGMEnT).

Who this might be right for
Heart DiseaseDiabetes
Griffin Hospital 240
Large-scale testing (Phase 3)Study completedNCT01313676
What this trial is testing

Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 16,568
Testing effectiveness (Phase 2)Study completedNCT05355402
What this trial is testing

Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia

Who this might be right for
HypertriglyceridemiaAtherosclerotic Cardiovascular DiseaseSevere Hypertriglyceridemia
Ionis Pharmaceuticals, Inc. 154
Not applicableStudy completedNCT00488865
What this trial is testing

RexMedical- Option* Vena Cava Filter IDE Study

Who this might be right for
Pulmonary Embolism
Rex Medical 100
Testing effectiveness (Phase 2)Looking for participantsNCT07783802
What this trial is testing

Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Who this might be right for
AtherosclerosisCardiovascular DiseaseObesity+3 more
Eli Lilly and Company 120
Not applicableStudy completedNCT02231398
What this trial is testing

NuMoM2b Heart Health Study

Who this might be right for
Pregnancy Complicated by Cardiovascular Disorders as Postpartum Condition, Delivered During Previous EpisodeBreathing-Related Sleep Disorder
RTI International 4,509
Large-scale testing (Phase 3)UnknownNCT00895505
What this trial is testing

D-Dimer Guided Oral Anticoagulant Treatment (OAT)

Who this might be right for
Deep Venous Thrombosis
University Hospital, Bonn 300
Not applicableStudy completedNCT05208346
What this trial is testing

Effects of Canola Oil and Coconut Oil on Postprandial Metabolism in Older Adults With Increased Cardiometabolic Risk

Who this might be right for
Cardiovascular DiseasesMetabolic Syndrome
University of Bonn 30
Post-approval studies (Phase 4)Ended earlyNCT00867815
What this trial is testing

PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Who this might be right for
Anterior Ischemic Optic Neuropathy
Bayer 10
Not applicableLooking for participantsNCT05924347
What this trial is testing

Early Scoliotic Changes in Children at Increased Risk for Scoliosis Development

Who this might be right for
Adolescent Idiopathic Scoliosis22q11.2 Deletion Syndrome
UMC Utrecht 120
Large-scale testing (Phase 3)Study completedNCT00571649
What this trial is testing

Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients

Who this might be right for
Venous Thromboembolism
Bayer 8,101
Next Page